Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Arm I Red Ginseng

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting2
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07524114Recruiting

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

NCT02906943Recruiting

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

NCT06561516Not ApplicableCompleted

Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer

Showing all 3 trials

Research Network

Common Treatments

  • Arm I Red Ginseng1

Active Sponsors

  • University Health Network, Toronto2
  • Princess Margaret Hospital, Canada2
  • Gangnam Severance Hospital1

Top Investigators

Related Conditions

  • Colorectal Cancer2
  • Breast Cancer2
  • Gastrointestinal Cancer2
  • Genitourinary Cancer2
  • Lung Cancer2

Activity Timeline